In women with genetic risk factors for ovarian cancer, approximately 72% of positive results would be accurate, while negative results would be correct nearly 100% of the time. A blood test detects early ovarian cancer risk by identifying precancerous STIC lesions via Tu-Stroma RNA, guiding prevention decisions.